Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
boston blog main
boston top stories
deals
life sciences
national blog main
national top stories
roche
avapritinib
biopharma
blueprint medicines
clinical trials
cstone pharmaceuticals
duchenne
eli lilly
europe blog main
europe top stories
european medicines agency
fda
fisogatinib
flatiron health
genentech
hepatocellular carcinoma
investing
jeff albers
licensing
m&a
medullary thyroid cancer
muscular dystrophy
non-small cell lung cancer
pralsetinib
san francisco blog main
san francisco top stories
sarepta therapeutics
selpercatinib
thermo fisher scientific
thyroid cancer
What
approval
2
×
fda
roche
2
×
betting
billion
biopharma
blueprint
cancer
candidate
currently
deal
drug
duchenne
gene
historic
marketing
medicine
medicines
muscle
pact
puts
recently
regulatory
ret
review
rna
sarepta
second
swiss
team
therapeutics
therapy
wins
won
Language
unset
Current search:
roche
×
approval
×
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal